IP Library Granted Patent US 12,186,331
Granted Patent B2
US 12,186,331 · App. 17/983,992 · Granted Jan 7, 2025

Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children

Inventors: Clara Lucia Garcia-Rodenas (Forel, CH); Jose Manuel Ramos Nieves (Lausanne, CH); Myriam Sandrine Steinmann (Echallens, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/702A23L33/125A23L33/40A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,331
App. No.
17/983,992
Granted
Jan 7, 2025
Kind
B2
Abstract

This invention relates to compositions for use in the promotion of the development and/or of the growth of the surface area of the small intestine and in the associated improvement of the digestive capacity in an infant or in a young child.

Claims (22)

1. A method of promoting the digestive capacity in a child in need thereof, the method comprising administering to the child a growing-up milk comprising at least one N-acetylated oligosaccharide and at least one fucosylated oligosaccharide, wherein the growing-up milk is administered in an effective amount for improving enterohepatic circulation in the child.

2. The method of claim 1 , for promoting the capacity to digest fat, liposoluble vitamins, proteins and carbohydrates in the child.

3. The method of claim 1 , for promoting the development and/or the growth of the surface area of the small intestine of the child.

4. The method of claim 1 , for promoting the increase of the villi length in the small intestine of the child.

5. The method of claim 1 , wherein the at least one N-acetylated oligosaccharide is selected from the group consisting of lacto-N-neotetraose (LNnT), lacto-N-tetraose (LNT), para-lacto-N-neohexaose (para-LNnH), disialyllacto-N-tetraose (DSLNT) and combinations thereof.

6. The method of claim 1 , wherein the at least one N-acetylated oligosaccharide comprises lacto-N-neotetraose (LNnT).

7. The method of claim 1 , wherein the at least one fucosylated oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3′fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and combinations thereof.

8. The method of claim 1 , wherein the at least one fucosylated oligosaccharide comprises a 2′ fucosyl-epitope.

9. The method of claim 1 , wherein the at least one fucosylated oligosaccharide comprises 2′-fucosyllactose (2′FL).

10. The method of claim 1 , wherein the growing-up milk comprises 2′-fucosyllactose and lacto-N-neotetraose (LNnT), or comprises an oligosaccharide mixture consisting of 2′-fucosyllactose (2′FL) and lacto-N-neotetraose (LNnT).

11. The method of claim 1 , wherein the at least one N-acetylated oligosaccharide and the at least one fucosylated oligosaccharide are present in a ratio N-acetylated oligosaccharide:fucosylated oligosaccharide of from 1:20 to 2:1.

12. The method of claim 1 , wherein

a. the at least one fucosylated oligosaccharide is in a total amount of 0.005-5 g/L of the growing-up milk and/or in a total amount of 0.004-3.8 g/100 g of the growing-up milk on a dry weight basis; and/or

b. the at least one N-acetylated oligosaccharide is in a total amount of 0.1-2.5 g/L of the growing-up milk and/or in a total amount of 0.08-1.9 g/100 g of the growing-up milk on a dry weight basis.

13. The method of claim 1 , wherein

a. the at least one fucosylated oligosaccharide(s) is in a total amount of 0.02-2 g/L of the growing-up milk and/or in a total amount of 0.015-1.5 g/100 g of the growing-up milk on a dry weight basis; and/or

b. the at least one N-acetylated oligosaccharide(s) is/are in a total amount of 0.5-1 g/L of the growing-up milk and/or in a total amount of 0.4-0.8 g/100 g of the growing-up milk on a dry weight basis.

14. The method of claim 1 , wherein

a. the at least one fucosylated oligosaccharide is in a total amount of 0.1-2.5 g/L of the growing-up milk and/or in a total amount of 0.08-1.9 g/100 g of the growing-up milk on a dry weight basis; and/or

b. the at least one N-acetylated oligosaccharide is in a total amount of 0.5-0.8 g/L of the growing-up milk and/or in a total amount of 0.4-0.6 g/100 g of the growing-up milk on a dry weight basis.

15. The method of claim 1 , wherein the growing-up milk comprises at least another oligosaccharide and/or a fiber and/or a precursor thereof selected from the group consisting of galacto-oligosaccharides (GOS), fructo-oligosaccharides (FOS), xylooligosaccharides (XOS), inulin, polydextrose, sialylated oligosaccharides, sialic acid, fucose and combinations thereof.

16. The method of claim 1 , the growing-up milk further comprises at least one probiotic in an amount of from 10 3 to 10 12 cfu/g of the growing-up milk (dry weight).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: GARCIA-RODENAS, CLARA LUCIA; RAMOS NIEVES, JOSE MANUEL; STEINMANN, MYRIAM SANDRINE
To: NESTEC S.A.
Reel/Frame 067459/0646 →
MERGER Recorded May 20, 2024
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 067459/0657 →
Priority Claims (1)
EP 17209456 · Dec 21, 2017 · regional
Continuity (2)
Continuation 16955495
Related Publication 20230084416A1 · Mar 16, 2023
References Cited (17)
US 20040115179A1 · Liu et al. · 2004 [cited by applicant]
US 20140286908A1 · Garcia-Rodenas et al. · 2014 [cited by applicant]
US 20180036327A1 · McConnell et al. · 2018 [cited by applicant]
US 20180153915A1 · Morrow · 2018 [cited by applicant]
US 20180228195A1 · Thakkar · 2018 [cited by applicant]
WO 2013025104 · 2013 [cited by applicant]
WO 2016176484 · 2016 [cited by applicant]
WO 2017021476A1 · 2017 [cited by applicant]
Lindquist et al. “Lipid digestion and absorption in early life: an update” Curr Opin Clin Nutr Metab Care, 2010, vol. 13, pp. 314-320. [cited by applicant]
Jantscher-Krenn et al. “Human milk oligosaccharides and their potential benefits for the breast-fed neonate” Minerva Pediatr, 2012, vol. 63, pp. 83-99. [cited by applicant]
Landberg et al. “Changes in Glycosylation of Human Bile-Salt-Stimulated Lipase during Lactation” Archives of Biochemistry and Biophysics, 2000, vol. 377, No. 2, pp. 246-254. [cited by applicant]
Kunz et al. “Oligosaccharides in Human Milk: Structural, Functional, and Metabolic Aspects” Annu. Rev. Nutr., 2000, vol. 20, pp. 699-722. [cited by applicant]
Holscher et al. “Human Milk Oligosaccharides Influence Maturation of Human Intestinal Caco-2Bbe and HT-29 Cell Lines” The Journal of Nutrition, 2014, vol. 144, pp. 586-591. [cited by applicant]
DeSesso, J. M., & Jacobson, C. F. (2001). Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food and chemical toxicology, 39(3), 209-228. (Year: 2001). [cited by applicant]
Office Action Received for Application No. CN201880082873.8, mailed on Sep. 4, 2023, 10 Pages (5 Pages of English Translation and 5 pages of Official Copy). [cited by applicant]
Huanlong, “Basic and Clinical Aspects of Intestinal Barrier Function”, 1st Edition, Jul. 31, 2007, pp. 36-40. [cited by applicant]
Office Action Received for Application No. CN201880082873.8, mailed on Jan. 20, 2024, 12 Pages (8 Pages of English Translation and 4 pages of Official Copy). [cited by applicant]